Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin-4 production and associated eosinophilia-Reference-Cited by-同舟云学术

Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin-4 production and associated eosinophilia

Published:1997-09 Issue:3 Volume:42 Page:313-318
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Smith Derek R.,Balashov Konstantin E.,Hafler David A.,Khoury Samia J.,Weiner Howard L.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference34 articles.

1. Immunologic Mechanisms and Therapy in Multiple Sclerosis

2. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?

3. EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON

4. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.

5. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New targets for old drugs;New Horizons in Natural Compound Research;2023

2. Cyclophosphamide in treatment of tumefactive multiple sclerosis;Multiple Sclerosis and Related Disorders;2021-01

3. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach;Neurochemistry International;2020-11

4. Fulminant Acute Disseminated Encephalomyelitis: A Remarkable Outcome with Cyclophosphamide;Journal of Pediatric Neurology;2020-09-21

5. Hookworm Treatment for Relapsing Multiple Sclerosis;JAMA Neurology;2020-09-01